| Primary |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
21.4% |
| Renal Transplant |
10.7% |
| Rheumatoid Arthritis |
6.5% |
| Aplastic Anaemia |
5.7% |
| Prophylaxis Against Transplant Rejection |
4.6% |
| Psoriasis |
3.4% |
| Diabetes Mellitus |
2.7% |
| Heart Transplant |
2.7% |
| Cardiovascular Event Prophylaxis |
2.3% |
| Hypertension |
2.3% |
| Drug Exposure During Pregnancy |
1.9% |
| Vitamin Supplementation |
1.9% |
| Pain |
1.5% |
| Transplant |
1.5% |
| Blood Triglycerides |
1.1% |
| Bone Marrow Transplant |
1.1% |
| Leukaemia |
1.1% |
| Liver Transplant |
1.1% |
| Stem Cell Transplant |
1.1% |
|
| Rash |
12.0% |
| Vomiting |
12.0% |
| Death |
8.0% |
| Tremor |
6.0% |
| Accidental Overdose |
4.0% |
| Blood Creatinine Increased |
4.0% |
| Drug Ineffective |
4.0% |
| Drug Level Decreased |
4.0% |
| Drug Level Increased |
4.0% |
| Graft Versus Host Disease |
4.0% |
| Haemoglobin Decreased |
4.0% |
| Nausea |
4.0% |
| Pneumonia |
4.0% |
| Product Quality Issue |
4.0% |
| Rash Generalised |
4.0% |
| Rash Papular |
4.0% |
| Urine Output Decreased |
4.0% |
| Urine Potassium Increased |
4.0% |
| Weight Decreased |
4.0% |
| Alopecia |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
23.9% |
| Drug Use For Unknown Indication |
16.7% |
| Prophylaxis Against Transplant Rejection |
14.4% |
| Aplastic Anaemia |
10.6% |
| Heart Transplant |
4.4% |
| Psoriasis |
4.4% |
| Renal Transplant |
4.4% |
| Rheumatoid Arthritis |
2.8% |
| Bone Marrow Transplant |
2.2% |
| Leukaemia |
2.2% |
| Neoplasm Malignant |
2.2% |
| Blood Cholesterol Increased |
1.7% |
| Hypertension |
1.7% |
| Stem Cell Transplant |
1.7% |
| Depression |
1.1% |
| Fibromyalgia |
1.1% |
| Liver Transplant |
1.1% |
| Lupus Nephritis |
1.1% |
| Pain |
1.1% |
| Pancreas Transplant |
1.1% |
|
| Hepatitis Acute |
15.4% |
| Graft Versus Host Disease |
10.3% |
| Psoriasis |
7.7% |
| Vomiting |
7.7% |
| Weight Decreased |
7.7% |
| Coagulopathy |
5.1% |
| Drug Intolerance |
5.1% |
| Drug Level Increased |
5.1% |
| Gastric Polyps |
5.1% |
| White Blood Cell Count Decreased |
5.1% |
| Blood Creatinine Increased |
2.6% |
| Diabetes Mellitus |
2.6% |
| Drug Level Decreased |
2.6% |
| Mandibulofacial Dysostosis |
2.6% |
| Musculoskeletal Stiffness |
2.6% |
| Myocardial Ischaemia |
2.6% |
| Nausea |
2.6% |
| Neoplasm |
2.6% |
| Night Sweats |
2.6% |
| Paraesthesia |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.6% |
| Renal Transplant |
8.4% |
| Hypertension |
7.5% |
| Prophylaxis Against Transplant Rejection |
6.1% |
| Drug Use For Unknown Indication |
5.8% |
| Imaging Procedure |
5.8% |
| Liver Transplant |
5.2% |
| Nuclear Magnetic Resonance Imaging |
4.9% |
| Computerised Tomogram Abdomen |
4.3% |
| Diabetes Mellitus |
4.1% |
| Oedema |
3.5% |
| Nuclear Magnetic Resonance Imaging Abdominal |
2.9% |
| Renal Failure Chronic |
2.9% |
| Colitis Ulcerative |
2.6% |
| Diarrhoea |
2.6% |
| Hepatitis C |
2.6% |
| Immunosuppression |
2.6% |
| Osteoporosis |
2.6% |
| Prophylaxis |
2.6% |
| Psoriasis |
2.3% |
|
| Renal Failure Acute |
24.3% |
| Ventricular Tachycardia |
9.5% |
| Weight Decreased |
9.5% |
| Vomiting |
8.1% |
| Thrombocytopenia |
6.8% |
| Tachycardia |
5.4% |
| Vision Blurred |
5.4% |
| Blood Pressure Increased |
2.7% |
| Death |
2.7% |
| Drug Ineffective |
2.7% |
| Immunosuppressant Drug Level Increased |
2.7% |
| Proteinuria |
2.7% |
| Pruritus |
2.7% |
| Renal Tubular Necrosis |
2.7% |
| Skin Hypertrophy |
2.7% |
| Thrombosis In Device |
2.7% |
| Wrong Technique In Drug Usage Process |
2.7% |
| Aplasia Pure Red Cell |
1.4% |
| Arthralgia |
1.4% |
| Atrial Fibrillation |
1.4% |
|
